CompletedPhase 2

A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

NCT02969369

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Neuuro-Pain Medical Center

Fresno, California, United States

+23 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2016-12-31
Enrollment: 39 participants
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Purpose: treatment

Locations (24)

Neuuro-Pain Medical CenterFresno, California, United States
Keck School of Medicine of USC/ University of Southern CaliforniaLos Angeles, California, United States
CiTrialsRiverside, California, United States
Georgetown University Hospial, Research Pharmacy ServciesWashington D.C., District of Columbia, United States
JEM Research InstituteAtlantis, Florida, United States
UHealth at Boca RatonBoca Raton, Florida, United States
Parkinson's Disease and Movement Disorders Center of Boca RatonBoca Raton, Florida, United States
University of Miami, Dept. of NeurologyMiami, Florida, United States
Compass ResearchOrlando, Florida, United States
Neurology Associates of Ormond BeachOrmond Beach, Florida, United States
Parkinson's Disease Treatment Center of Southwest FloridaPort Charlotte, Florida, United States
Suncoast Neuroscience Associates, Inc.St. Petersburg, Florida, United States
University of Florida Parkinson's Disease and Movement Disorder's CenterTampa, Florida, United States
The Emory ClinicAtlanta, Georgia, United States
Rush University Medical CenterChicago, Illinois, United States
University of Kansas Medical CenterKansas City, Kansas, United States
Henry Ford West Bloomfield HospitalWest Bloomfield, Michigan, United States
Washington University School of MedicineSt Louis, Missouri, United States
Icahn School of Medicine at Mount SinaiNew York, New York, United States
Brian MadduxCincinnati, Ohio, United States
The Movement Disorder Clinic of OklahomaTulsa, Oklahoma, United States
Thomas Jefferson UniversityPhiladelphia, Pennsylvania, United States
University of Pennsylvania, Department of NeurologyPhiladelphia, Pennsylvania, United States
Inland Northwest ResearchSpokane, Washington, United States